Immune checkpoint inhibitors (ICIs) have transformed treatment for many types of cancer. In some patients, however, ICIs are associated with immune-related complications that can affect the kidneys. These complications sometimes ...
Apr 22, 2026
0
4
Understanding and categorizing the various types of tubulointerstitial responses in acute kidney injury (AKI) may lead to the development of new treatments for the condition, according to Yale School of Medicine researchers ...
Apr 15, 2025
0
13
Researchers from Johns Hopkins Medicine and Yale University have collaborated on the development and application of a diagnostic model to detect acute interstitial nephritis (AIN) in patients, which could have a lasting impact ...
Nov 12, 2024
0
14
Immune checkpoint inhibitors (ICIs) are a class of immunotherapy that have revolutionized the treatment of cancer. However, they can cause a wide variety of autoimmune toxicities, including immune checkpoint inhibitor-associated ...
Sep 6, 2024
0
40
In a study led by Johns Hopkins Medicine, in collaboration with Yale School of Medicine, researchers have identified a biomarker found via a simple urine test that can be used to diagnose acute tubulointerstitial nephritis ...
Jul 5, 2023
0
57
